Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality
- 1 December 2001
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 17 (4) , 233-240
- https://doi.org/10.1185/030079901753403126
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: